Home    About Us    Medic-All    Bio B2B    Hot Topic     Expo     Login | Join Now          
PharmaEssentia Corporation (Taipei Exchange:6446) is a fully integrated global biopharmaceutical company delivering efficacious, safe and cost-effective therapeutic products for the treatment of human diseases while aiming to bring long lasting value to stakeholders. PharmaEssentia was founded in 2003 by a group of Taiwanese-American executives and high-ranking scientists from leading U.S. biotechnology and pharmaceutical companies in order to develop treatments for myeloproliferative neoplasms, hepatitis and other diseases. The company is committed to the improvement of health and quality of life for patients suffering from these diseases. The Company's world-class cGMP biologics facility in Taichung is certified by the Taiwan Food and Drug Administration (TFDA) and is designed and operated to be compliant with all U.S. FDA and EMA requirements.
 
  • Ching-leou Teng,<br/>Chairwoman

    Ching-leou Teng,
    Chairwoman

    - Ph.D. in Pharmaceutics, University of Michigan
    - Former Reviewer of Pharmacokinetics Evaluation Branch, Division of Biopharmaceutics, FDA
  • Jack Hwang,<br/>General Manager

    Jack Hwang,
    General Manager

    - Ph.D. in Organic Chemistry, University of Pennsylvania
    - Former Senior Director of Optimer Pharma
  • Ko-Chung Lin,<br/>Founder & CEO

    Ko-Chung Lin,
    Founder & CEO

    - Ph.D. in Organic Chemistry, University of Missouri
    - Former Head of Adentri™ Program & Pegylated-Avonex™ Program, Biogen Inc.
    - The lead inventor of PEG-IFN b (Plegridy), Biogen Inc.
PharmaEssentia Corporation (Taipei Exchange:6446) is a fully integrated global biopharmaceutical company delivering efficacious, safe and cost-effective therapeutic products for the treatment of human diseases while aiming to bring long lasting value to stakeholders. PharmaEssentia was founded in 2003 by a group of Taiwanese-American executives and high-ranking scientists from leading U.S. biotechnology and pharmaceutical companies in order to develop treatments for myeloproliferative neoplasms, hepatitis and other diseases. The company is committed to the improvement of health and quality of life for patients suffering from these diseases. The Company's world-class cGMP biologics facility in Taichung is certified by the Taiwan Food and Drug Administration (TFDA) and is designed and operated to be compliant with all U.S. FDA and EMA requirements.
 
  Video
Pipeline & Platform